Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.
Clinical trial NCT06452433 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06452433
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2027-12-12
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.